GlassScriptPhysician profile
Manoj M Abraham
NPI 1952500159
$3,446.89
in general payments reported to CMS, 2019-2025
6 companies · $578 in 2025
The $578 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $11.99 · 2021: $208 · 2022: $237 · 2023: $1,579 · 2024: $713 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690 · Travel and Lodging: $1,104 · Entertainment: $75.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.51 |
| Travel and Lodging | $1,103.80 |
| Entertainment | $75.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,401.23 | 2021-2023 | Cvi Contact Lens |
| Alcon Vision LLC | $721.95 | 2019-2025 | Precision7, Dailies Total1, Total30 |
| Bausch & Lomb Americas INC. | $680.06 | 2023-2025 | Infuse, Ultra Multifocal Toric |
| Johnson & Johnson Vision Care, INC. | $398.86 | 2021-2023 | Acuvue |
| Rxsight INC | $125.14 | 2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Optos, INC. | $119.65 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.